How Do Diabetes and Steroids Affect DXA and FRAX Accuracy?

Yes, having diabetes (Type 1 or Type 2) or taking long-term systemic steroid medications (glucocorticoids, like oral prednisone) can mean that your bone density scan (DXA) and fracture risk score (FRAX) may underestimate your true risk of breaking a bone ^[1][2][3].

A DXA scan helps diagnose osteoporosis by measuring bone density, and the FRAX calculator estimates the 10-year probability of a major bone fracture ^[4]. While these are valuable standard tools, they have distinct limitations when evaluating secondary causes of bone loss ^[2][5]. Because of this, a seemingly normal test result does not automatically rule out clinically important risk ^[6].

Why Your DXA Scan Might Not Tell the Whole Story

A DXA scan compares your bone density to a healthy young adult to generate a T-score. DXA is excellent at measuring bone quantity (density), but it does not measure bone quality—the microarchitecture, protein structure, and overall strength of the bone ^[1].

• Type 1 Diabetes: People with Type 1 diabetes have a substantially higher risk of experiencing a bone fracture. However, their DXA results often show only a modest drop in bone density ^[7]. The scan misses underlying structural issues, such as thinner cortical bone (the hard outer layer of the bone) and lower overall strength ^[8].
• Type 2 Diabetes: It is common for people with Type 2 diabetes to have average or even higher-than-average bone density on a DXA scan, yet still face an increased fracture risk ^[9]. This occurs because diabetes can alter bone turnover (how the body replaces old bone) and damage the collagen protein structure, making the bone more brittle ^[10].
• Systemic Steroid Use: Long-term use of systemic glucocorticoids damages bone tissue and increases fracture risk rapidly, sometimes early in treatment ^[3]. Because this affects the bone’s internal quality, relying on a DXA scan alone might miss early signs of fragility ^[6]. (Note: Never stop or change a prescribed glucocorticoid medication without medical advice, as abrupt stopping can be dangerous).

How Diabetes and Steroids Impact Your FRAX Score

The FRAX tool calculates your estimated risk of a major bone fracture (like a hip or spine fracture) over the next 10 years. However, studies show it often underestimates this risk for patients with diabetes and those on glucocorticoids ^[2][11].

The Diabetes “Blind Spot”

The standard online FRAX questionnaire does not include a check box for Type 1 or Type 2 diabetes ^[2]. Because FRAX incorporates your DXA T-score (which might look artificially reassuring), it can calculate a risk score that is lower than your actual risk, particularly for hip fractures in Type 2 diabetes ^[11][12].

To compensate, doctors sometimes use clinical “workarounds” to force the tool to output a more realistic estimate. For example, some clinicians might check the FRAX box for Rheumatoid Arthritis as a substitute, or use American Diabetes Association guidance to interpret a DXA T-score as 0.5 points lower than what is printed on the report ^[11][13]. These are clinician-directed approximations, not universally validated rules. Patients should not manipulate the online calculator themselves; instead, ask your doctor how they interpret your score.

The Problem with the Steroid Checkbox

When calculating your risk, the standard FRAX tool simply asks a “yes or no” question regarding glucocorticoid use ^[14]. It is designed for typical oral steroid exposures, but it does not ask what exact dose you take or your total duration of use. Because fracture risk is heavily dependent on both dose and duration ^[15], a simple “yes” may fail to capture the severe risk posed by long-term or high-dose treatments ^[16]. Always bring your exact drug, dose, route, and treatment dates to your appointment.

Trabecular Bone Score (TBS): An Optional Risk-Refinement Tool

To get a more personalized assessment of your bone health, your doctor might utilize a tool called a Trabecular Bone Score (TBS).

• What is it? TBS is an indirect texture-derived index; it is a software program that re-analyzes the digital images from your existing lower spine DXA scan ^[5].
• What does it do? While it does not directly view microscopic bone, it evaluates the visual texture of your spongy bone to estimate its internal microarchitecture ^[5].
• Why it helps: When combined with your FRAX score (creating a “TBS-adjusted FRAX”), it can modestly improve the accuracy of your fracture risk estimate, particularly if your risk is near the threshold for starting medication ^[17][4].

Limitations: TBS is an adjunct tool, not a replacement for clinical judgment. Its availability varies by facility, and its accuracy can be limited by poor image quality, spinal arthritis (degeneration), or higher body weight and central adiposity ^[4][18].

Putting It All Together: Next Steps

If you have diabetes or take long-term steroids, an abnormal risk estimate does not mean a fracture is inevitable, and a normal result does not mean you are perfectly safe. Clinicians do not rely on these tests alone. They combine your DXA and FRAX results with your age, medication history, fall history, and diabetes complications to make comprehensive treatment decisions ^[11][15].

Because you can have hidden spinal fractures even with a non-osteoporotic DXA score ^[6], your doctor may recommend a vertebral fracture assessment (spine imaging via X-ray or specialized DXA) if you have experienced unexplained back pain, measurable height loss, or long-term steroid exposure.